Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis - Comparison with the preliminary American College of Rheumatology and the World Health Organization International League Against Rheumatism criteria
Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis - Comparison with the preliminary American College of Rheumatology and the World Health Organization International League Against Rheumatism criteria
复制标题
DOI：
10.1002/art.1780390105
复制
发表时间：
1996-01-01
影响因子：
--
通讯作者：
vanRiel, PLCM
中科院分区：
文献类型：
--
作者：
vanGestel, AM;Prevoo, MLL;vanRiel, PLCM
Objective.验证欧洲抗风湿联盟（EULAR）、美国风湿病学会（ACR）、世界卫生组织（WHO）/国际抗风湿联盟（ILAR）对类风湿关节炎（RA）的反应标准。EULAR反应标准结合基线变化和随访期间获得的疾病活动水平制定。在一项比较羟氯喹和柳氮磺胺吡啶的试验中，我们研究了结构（放射学进展），标准（功能能力）和判别效度。EULAR反应标准具有良好的结构效度、效标效度和判别效度，ACR和WHO/ILAR反应标准具有良好的效标效度。EULAR反应标准比ACR和WHO/ILAR反应标准对RA的结构效度和判别效度更好。
Objective. To validate the European League Against Rheumatism (EULAR), the American College of Rheumatology (ACR), acid the World Health Organization (WHO)/International League Against Rheumatism (ILAR) response criteria for rheumatoid arthritis (RA).Methods. EULAR response criteria were developed combining change from baseline and level of disease activity attained during followup, In a trial comparing hydroxychloroquine and sulfasalazine, we studied construct (radiographic progression), criterion (functional capacity), and discriminant validity.Results. EULAR response criteria had good construct, criterion, and discriminant validity, ACR and WHO/ILAR criteria showed only good criterion validity.Conclusion. EULAR response criteria showed better construct and discriminant validity than did the ACR and the WHO/ILAR response criteria for RA.